Moderna
MRNA
#221
Rank
S$131.78 B
Marketcap
S$325.70
Share price
5.27%
Change (1 day)
910.88%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Operating Margin for Moderna (MRNA)

Operating Margin as of November 2026 (TTM): -137.78%

According to Moderna 's latest financial reports and stock price the company's current Operating Margin is -137.78%. At the end of 2022 the company had an Operating Margin of 49.71%.

Operating Margin history for Moderna from 2018 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202249.71%-33.64%
202174.90%-127.62%
2020-271.24%-74.69%
2019-1,071.52%241.5%
2018-313.77%116.92%
2017-144.65%-31.74%
2016-211.91%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58%-125.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
22.03%-115.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
32.40%-123.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-118.00%-14.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-61.01%-55.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-1,576.98% 1,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
8.70%-106.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
6.21%-104.51%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.